back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-09-12 11:44 Tx date 2025-09-12 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$264.98
+750 vol $0.3533 each |
15,200 | |
| Filed 2025-09-11 16:13 Tx date 2025-09-11 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$243.75
+650 vol $0.375 each |
14,450 | |
| Filed 2025-07-31 17:56 Tx date 2025-07-28 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2025-07-31 17:45 Tx date 2025-04-29 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-26 13:20 Tx date 2025-06-24 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-124,200 vol |
13,800 | |
| Filed 2025-06-20 19:00 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+200,000 vol $0.05 each |
200,000 | |
| Filed 2025-06-20 18:57 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
2,555,549 | |
| Filed 2025-06-10 18:43 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
||
| Filed 2025-06-10 11:52 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+200,000 vol $0.10 each |
||
| Filed 2025-06-10 18:44 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
752,692 | |
| Filed 2025-06-10 18:43 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Bacha, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+500,000 vol $0.10 each |
2,555,549 | |
| Filed 2025-06-10 11:52 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+200,000 vol $0.10 each |
200,000 | |
| Filed 2025-06-10 11:50 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$10,000
+200,000 vol $0.05 each |
200,000 | |
| Filed 2025-06-10 11:41 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 11:39 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 11:19 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 11:14 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 11:12 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 11:11 Tx date 2025-04-01 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Kideckel, David
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-06 17:36 Tx date 2025-06-06 |
$RKV
Rakovina Therapeutics Inc. - formerly, Vincero Capital Corp. |
Meshcherekov, Yevgeniy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250.00
+5,000 vol $0.05 each |
138,000 |